JSF Financial’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-828
| Closed | -$870K | – | 134 |
|
|
2024
Q3 | $870K | Buy |
828
+68
| +9% | +$71.5K | 0.25% | 59 |
|
|
2024
Q2 | $799K | Buy |
760
+49
| +7% | +$51.5K | 0.24% | 56 |
|
|
2024
Q1 | $684K | Buy |
711
+53
| +8% | +$51K | 0.21% | 64 |
|
|
2023
Q4 | $578K | Buy |
658
+4
| +0.6% | +$3.51K | 0.2% | 60 |
|
|
2023
Q3 | $538K | Buy |
+654
| New | +$538K | 0.21% | 60 |
|
|
2023
Q2 | – | Sell |
-761
| Closed | -$625K | – | 118 |
|
|
2023
Q1 | $625K | Buy |
761
+59
| +8% | +$48.5K | 0.23% | 58 |
|
|
2022
Q4 | $506K | Buy |
702
+17
| +2% | +$12.3K | 0.19% | 76 |
|
|
2022
Q3 | $472K | Buy |
+685
| New | +$472K | 0.18% | 74 |
|
|
2022
Q2 | – | Sell |
-296
| Closed | -$207K | – | 118 |
|
|
2022
Q1 | $207K | Buy |
+296
| New | +$207K | 0.09% | 108 |
|
|
2020
Q4 | – | Sell |
-365
| Closed | -$204K | – | 95 |
|
|
2020
Q3 | $204K | Buy |
+365
| New | +$204K | 0.16% | 72 |
|